TABLE 2.
Visit characteristic | n | High satisfaction† (n = 81) (n, %) | Low satisfaction (n = 13) (n, %) | OR | 95% CI |
---|---|---|---|---|---|
Patient gender | |||||
Female | 53 | 45 (85) | 8 (15) | Reference | |
Male | 41 | 36 (88) | 5 (12) | 1.28 | 0.39–4.25 |
Patient age (years) | |||||
<18 | 30 | 26 (87) | 4 (13) | Reference | |
18–29 | 37 | 33 (89) | 4 (11) | 1.27 | 0.29–5.57 |
30+ | 27 | 22 (82) | 5 (19) | 0.68 | 0.16–2.84 |
Diagnostic category | |||||
Hematological malignancy | 61 | 54 (89) | 7 (12) | Reference | |
Solid tumor | 29 | 25 (86) | 4 (14) | 0.81 | 0.22–3.02 |
Other | 4 | 2 (50) | 2 (50) | 0.13 | 0.02–1.07 |
Week of visit | |||||
1–5 | 31 | 23 (28) | 8 (62) | Reference | |
6‐7 | 27 | 23 (28) | 4 (31) | 2.00 | 0.53– 7.58 |
8–10 | 36 | 36 (44) | 1 (8) | 12.17 | 1.43– 103.93 |
Provider VV volume‡ | |||||
Low (<10 VV) | 20 | 11 (56) | 9 (45) | Reference | |
High (20–30 VV) | 74 | 70 (95) | 4 (5) | 14.32 | 3.76– 54.60 |
Risk for late effects | |||||
Low | 29 | 26 (90) | 3 (10) | Reference | |
Moderate | 29 | 27 (93) | 2 (7) | 1.56 | 0.24–10.09 |
High | 36 | 28 (78) | 8 (22) | 0.40 | 0.10–1.69 |
Met clinical care objectives (n = 93) | |||||
No | 51 | 40 (78) | 11 (22) | Reference | |
Yes | 42 | 40 (95) | 2 (5) | 5.55 | 1.15– 26.41 |
Abbreviation: VV, virtual visit.
†High satisfaction group includes all visits rated “completely” or “ very” satisfied.
‡Four providers with <10 VV classified as low volume; three providers with >20–30 VV classified as high volume.
OR in bold are significant at p < .05.